Target intelligence / Profile preview

ER degradation enhancer, mannosidase alpha-like 1 pseudogene (ENSG00000228480)

Target
ENSG00000228480
Molecular classification
Pseudogene
01

Overview

ER degradation enhancer, mannosidase alpha-like 1 pseudogene (ENSG00000228480) is annotated as a *pseudogene* related to the functional gene *EDEM1* (ER degradation-enhancing alpha-mannosidase-like protein 1)[3]. Pseudogenes are genomic sequences similar to known genes but do not encode functional proteins due to mutations such as frameshifts or premature stop codons[7]. Recent research indicates some pseudogenes can play regulatory roles at the RNA level, such as acting as microRNA decoys or generating small RNAs, potentially modulating the expression of their parent or related genes[5][7]. However, there is no direct evidence that this specific pseudogene is involved in protein coding, therapeutic targeting, or well-characterized disease pathways. In summary, ENSG00000228480 is not a protein-coding gene or validated therapeutic target, but a pseudogene, and should not be considered a canonical receptor, enzyme, or other druggable molecular entity at this time[3][5][7].

Other names
EDEM1 pseudogeneER degradation enhancer mannosidase alpha-like 1 pseudogene[3]
02

Biological functions

May function as a noncoding RNA decoy for microRNAs, possibly affecting the regulation of its parental or related genes, but no confirmed protein or canonical molecular activity[5][7]
03

Disease associations

No direct disease association or role described; some pseudogenes may participate in cancer or other diseases through regulatory noncoding functions, but this is not established for ENSG00000228480 specifically[5][7]

Beyond the preview

Go deeper on ER degradation enhancer, mannosidase alpha-like 1 pseudogene (ENSG00000228480).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ER degradation enhancer, mannosidase alpha-like 1 pseudogene (ENSG00000228480).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call